The overall performance is measured by means of tumor segmentation accuracy, as well as by the merit figures of two RSs, one for tumor grading and the other one for isocitrate dehydrogenase‐1 (IDH1) status prediction. The gene discussed is IDH1; the disease is neoplasm.